Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/hae.14045 http://scihub22266oqcxt.onion/10.1111/hae.14045 32384183!7272941!32384183     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32384183.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Haemophilia 2020 ; 26 (5): 768-772 Nephropedia Template TP {{tp|p=32384183|t=2020. In-hospital management of persons with haemophilia and COVID-19: Practical guidance |pdf=|usr=}}{{32384183}} gab.com Text In-hospital management of persons with haemophilia and COVID-19: Practical guidance JO: Haemophilia http://www.kidney.de/pget.php?&tw=1&pmid=32384183 #FOAvip A new disease (COVID-19) caused by a coronavirus (SARS-CoV-2) that appeared in China at the end of 2019 is currently spreading globally. This emerging virus is mainly responsible for respiratory tract infections and potentially fatal pneumonia, mainly in more frail patients. Persons with haemophilia of variable severity and from all parts of the world will likely be infected and develop COVID-19. We here propose practical guidance for the in-hospital specific management of haemophilia persons with COVID-19 including their possible transfer to the intensive care unit. Rapid identification of the haemophilia status, undelayed and regular liaison with the haemophilia team, proper therapy with factor concentrates or alternative treatments appear instrumental to prevent haemophilia-related complications in this setting. Information of patients and their families about COVID-19, psychological support and good appreciation of the impact of haemophilia on therapeutic decisions including end-of-life directives are also addressed. Twit Text FOAVip In-hospital management of persons with haemophilia and COVID-19: Practical guidance ????Haemophilia http://www.kidney.de/pget.php?&tw=1&pmid=32384183 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32384183 #FOAvip English Wikipedia <ref>{{Cite pmid|32384183}}</ref> In-hospital management of persons with haemophilia and COVID-19: Practical guidance #MMPMID32384183 Hermans C; Lambert C; Sogorb A; Wittebole X; Belkhir L; Yombi JC Haemophilia 2020[Sep]; 26 (5): 768-772 PMID32384183show ga A new disease (COVID-19) caused by a coronavirus (SARS-CoV-2) that appeared in China at the end of 2019 is currently spreading globally. This emerging virus is mainly responsible for respiratory tract infections and potentially fatal pneumonia, mainly in more frail patients. Persons with haemophilia of variable severity and from all parts of the world will likely be infected and develop COVID-19. We here propose practical guidance for the in-hospital specific management of haemophilia persons with COVID-19 including their possible transfer to the intensive care unit. Rapid identification of the haemophilia status, undelayed and regular liaison with the haemophilia team, proper therapy with factor concentrates or alternative treatments appear instrumental to prevent haemophilia-related complications in this setting. Information of patients and their families about COVID-19, psychological support and good appreciation of the impact of haemophilia on therapeutic decisions including end-of-life directives are also addressed. |*Disease Management[MESH] |COVID-19/complications/*therapy[MESH] |Hemophilia A/complications/*therapy[MESH] |Hospitalization[MESH] |Humans[MESH] |Intensive Care Units[MESH]In-hospital management of persons with haemophilia and COVID-19: Pract(epmc).pdf DeepDyve Pubget Overpricing